Patricia Cowan
Concepts (236)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Overweight | 6 | 2024 | 217 | 1.060 |
Why?
| Learning | 2 | 2022 | 159 | 0.980 |
Why?
| Obesity | 16 | 2024 | 1108 | 0.910 |
Why?
| Students, Nursing | 2 | 2022 | 58 | 0.890 |
Why?
| Adiposity | 2 | 2024 | 133 | 0.850 |
Why?
| Faculty, Nursing | 2 | 2022 | 22 | 0.840 |
Why?
| Kidney Transplantation | 10 | 2015 | 175 | 0.660 |
Why?
| Education, Nursing, Graduate | 2 | 2016 | 20 | 0.640 |
Why?
| Physicians | 1 | 2022 | 230 | 0.640 |
Why?
| Prediabetic State | 2 | 2016 | 19 | 0.630 |
Why?
| Men | 1 | 2015 | 7 | 0.520 |
Why?
| Fellowships and Scholarships | 1 | 2015 | 111 | 0.470 |
Why?
| Diabetes Mellitus, Type 2 | 4 | 2016 | 486 | 0.460 |
Why?
| Weight Gain | 5 | 2015 | 239 | 0.400 |
Why?
| Body Mass Index | 10 | 2024 | 656 | 0.380 |
Why?
| Body Composition | 6 | 2024 | 319 | 0.370 |
Why?
| Nursing Education Research | 3 | 2022 | 35 | 0.370 |
Why?
| Heart Rate | 7 | 2013 | 298 | 0.350 |
Why?
| Kidney Failure, Chronic | 5 | 2017 | 200 | 0.330 |
Why?
| Humans | 45 | 2024 | 50208 | 0.330 |
Why?
| Leadership | 2 | 2022 | 101 | 0.310 |
Why?
| Education, Professional | 1 | 2008 | 5 | 0.310 |
Why?
| Health Occupations | 1 | 2008 | 20 | 0.300 |
Why?
| Dyslipidemias | 1 | 2007 | 36 | 0.290 |
Why?
| Exercise | 7 | 2013 | 503 | 0.270 |
Why?
| Cardiovascular Diseases | 2 | 2011 | 443 | 0.270 |
Why?
| Blood Glucose | 4 | 2016 | 435 | 0.270 |
Why?
| Male | 29 | 2024 | 25399 | 0.260 |
Why?
| Internet | 1 | 2008 | 258 | 0.260 |
Why?
| Adolescent | 11 | 2024 | 6390 | 0.250 |
Why?
| Insulin Resistance | 3 | 2016 | 262 | 0.250 |
Why?
| Caregivers | 2 | 2017 | 212 | 0.240 |
Why?
| Meta-Analysis as Topic | 1 | 2004 | 38 | 0.240 |
Why?
| Sirolimus | 2 | 2003 | 62 | 0.230 |
Why?
| Insulin | 5 | 2008 | 456 | 0.220 |
Why?
| Immunosuppressive Agents | 3 | 2003 | 222 | 0.220 |
Why?
| Absorptiometry, Photon | 1 | 2024 | 153 | 0.220 |
Why?
| Female | 29 | 2024 | 26635 | 0.220 |
Why?
| Adipose Tissue | 2 | 2024 | 187 | 0.220 |
Why?
| Evidence-Based Medicine | 1 | 2004 | 247 | 0.210 |
Why?
| Hypertrophy, Left Ventricular | 2 | 2013 | 40 | 0.200 |
Why?
| Teaching | 1 | 2022 | 114 | 0.190 |
Why?
| Nurses | 1 | 2020 | 49 | 0.180 |
Why?
| Risk Factors | 12 | 2015 | 3629 | 0.180 |
Why?
| Graft Rejection | 1 | 2000 | 168 | 0.170 |
Why?
| Hospitals | 1 | 2020 | 175 | 0.170 |
Why?
| Cohort Studies | 4 | 2016 | 1422 | 0.170 |
Why?
| Child | 10 | 2016 | 6851 | 0.160 |
Why?
| Age Factors | 3 | 2016 | 1092 | 0.150 |
Why?
| Islets of Langerhans | 2 | 2008 | 24 | 0.150 |
Why?
| Electrocardiography, Ambulatory | 4 | 2013 | 23 | 0.140 |
Why?
| Pancreas Transplantation | 3 | 2003 | 21 | 0.140 |
Why?
| Nurses, Male | 1 | 2016 | 1 | 0.140 |
Why?
| Regression Analysis | 2 | 2016 | 395 | 0.140 |
Why?
| Schools, Nursing | 1 | 2016 | 4 | 0.140 |
Why?
| Sex Factors | 2 | 2016 | 697 | 0.140 |
Why?
| Vulnerable Populations | 1 | 2016 | 45 | 0.140 |
Why?
| Multivariate Analysis | 2 | 2016 | 581 | 0.140 |
Why?
| Tissue Donors | 2 | 2008 | 113 | 0.140 |
Why?
| Education, Nursing | 1 | 2016 | 26 | 0.130 |
Why?
| Carboxypeptidase H | 1 | 2015 | 1 | 0.130 |
Why?
| Receptors, Dopamine D4 | 1 | 2015 | 10 | 0.130 |
Why?
| Hypoglycemic Agents | 2 | 2007 | 168 | 0.130 |
Why?
| Adaptation, Psychological | 1 | 2017 | 223 | 0.130 |
Why?
| Dopamine Plasma Membrane Transport Proteins | 1 | 2015 | 44 | 0.130 |
Why?
| Achievement | 1 | 2015 | 39 | 0.130 |
Why?
| Career Choice | 1 | 2016 | 111 | 0.130 |
Why?
| Minority Groups | 1 | 2016 | 132 | 0.130 |
Why?
| Prevalence | 5 | 2011 | 951 | 0.120 |
Why?
| Receptors, Dopamine D2 | 1 | 2015 | 17 | 0.120 |
Why?
| Adult | 20 | 2016 | 13324 | 0.120 |
Why?
| Physical Endurance | 2 | 2005 | 30 | 0.120 |
Why?
| Qualitative Research | 3 | 2020 | 336 | 0.120 |
Why?
| Glucagon | 2 | 2004 | 22 | 0.120 |
Why?
| Protein Precursors | 2 | 2004 | 43 | 0.120 |
Why?
| Depressive Disorder | 1 | 2016 | 339 | 0.110 |
Why?
| United States | 5 | 2020 | 4874 | 0.110 |
Why?
| Octreotide | 2 | 2004 | 9 | 0.110 |
Why?
| Educational Measurement | 1 | 2015 | 207 | 0.110 |
Why?
| Electrocardiography | 2 | 2013 | 262 | 0.110 |
Why?
| Physical Fitness | 1 | 2013 | 55 | 0.110 |
Why?
| Child Welfare | 1 | 2013 | 54 | 0.110 |
Why?
| Blood Pressure | 3 | 2011 | 524 | 0.110 |
Why?
| Clinical Competence | 1 | 2016 | 392 | 0.110 |
Why?
| Peptide Fragments | 2 | 2004 | 213 | 0.110 |
Why?
| Self Efficacy | 1 | 2013 | 129 | 0.110 |
Why?
| Glucagon-Like Peptide 1 | 3 | 2008 | 31 | 0.100 |
Why?
| Motor Activity | 1 | 2013 | 229 | 0.100 |
Why?
| Depression | 1 | 2017 | 570 | 0.100 |
Why?
| Sex Offenses | 1 | 2013 | 72 | 0.100 |
Why?
| Risk Assessment | 1 | 2016 | 1262 | 0.100 |
Why?
| Retrospective Studies | 6 | 2016 | 6134 | 0.100 |
Why?
| Long QT Syndrome | 1 | 2011 | 13 | 0.090 |
Why?
| Diet | 2 | 2012 | 557 | 0.090 |
Why?
| Health Promotion | 1 | 2013 | 267 | 0.090 |
Why?
| Calcium, Dietary | 1 | 2010 | 13 | 0.090 |
Why?
| Cell Separation | 2 | 2008 | 90 | 0.090 |
Why?
| Heart Conduction System | 1 | 2010 | 24 | 0.090 |
Why?
| Child, Preschool | 2 | 2016 | 3883 | 0.090 |
Why?
| Kidney Diseases | 1 | 2012 | 214 | 0.090 |
Why?
| Pilot Projects | 4 | 2015 | 697 | 0.080 |
Why?
| Glucose Intolerance | 1 | 2009 | 27 | 0.080 |
Why?
| Death, Sudden, Cardiac | 2 | 2000 | 57 | 0.080 |
Why?
| Insulin-Secreting Cells | 1 | 2008 | 23 | 0.080 |
Why?
| Middle Aged | 12 | 2015 | 12206 | 0.080 |
Why?
| Liver Transplantation | 2 | 2001 | 150 | 0.080 |
Why?
| Energy Intake | 4 | 2015 | 165 | 0.080 |
Why?
| Heart Diseases | 1 | 2011 | 211 | 0.080 |
Why?
| Education, Continuing | 1 | 2008 | 21 | 0.080 |
Why?
| Stress Disorders, Post-Traumatic | 1 | 2013 | 365 | 0.080 |
Why?
| Quality of Life | 3 | 2014 | 839 | 0.080 |
Why?
| Hypolipidemic Agents | 1 | 2007 | 27 | 0.070 |
Why?
| Anti-Obesity Agents | 1 | 2007 | 18 | 0.070 |
Why?
| Young Adult | 5 | 2016 | 3981 | 0.070 |
Why?
| Islets of Langerhans Transplantation | 1 | 2006 | 2 | 0.070 |
Why?
| Analysis of Variance | 4 | 2013 | 564 | 0.070 |
Why?
| Dietary Carbohydrates | 2 | 2004 | 86 | 0.070 |
Why?
| Veterans | 1 | 2013 | 560 | 0.070 |
Why?
| Tissue and Organ Harvesting | 1 | 2006 | 23 | 0.070 |
Why?
| Antihypertensive Agents | 1 | 2007 | 121 | 0.070 |
Why?
| Life Style | 1 | 2007 | 141 | 0.070 |
Why?
| Metformin | 1 | 2007 | 65 | 0.070 |
Why?
| Attitude to Health | 1 | 2007 | 191 | 0.070 |
Why?
| Tennessee | 3 | 2016 | 37 | 0.060 |
Why?
| Motivation | 1 | 2007 | 273 | 0.060 |
Why?
| Aged | 7 | 2015 | 9405 | 0.060 |
Why?
| Primary Health Care | 1 | 2009 | 360 | 0.060 |
Why?
| Pyruvic Acid | 1 | 2005 | 22 | 0.060 |
Why?
| Glucose Tolerance Test | 4 | 2008 | 56 | 0.060 |
Why?
| Glycemic Index | 1 | 2004 | 3 | 0.060 |
Why?
| Bicycling | 1 | 2004 | 25 | 0.060 |
Why?
| Task Performance and Analysis | 1 | 2004 | 52 | 0.060 |
Why?
| Statistics as Topic | 1 | 2004 | 87 | 0.060 |
Why?
| Exercise Test | 2 | 2005 | 127 | 0.060 |
Why?
| Inflammation | 1 | 2008 | 604 | 0.060 |
Why?
| Anthropometry | 3 | 2013 | 92 | 0.060 |
Why?
| Mycophenolic Acid | 1 | 2003 | 18 | 0.060 |
Why?
| Calcium | 1 | 2005 | 400 | 0.050 |
Why?
| Patient Selection | 2 | 2000 | 253 | 0.050 |
Why?
| Eating | 1 | 2003 | 161 | 0.050 |
Why?
| Renal Dialysis | 2 | 2000 | 170 | 0.050 |
Why?
| Dietary Supplements | 1 | 2005 | 434 | 0.050 |
Why?
| Transplantation Immunology | 1 | 2000 | 5 | 0.050 |
Why?
| Intestinal Absorption | 1 | 2000 | 46 | 0.050 |
Why?
| Weight Loss | 1 | 2003 | 238 | 0.050 |
Why?
| Workflow | 1 | 2020 | 51 | 0.050 |
Why?
| Drug Costs | 1 | 2000 | 39 | 0.050 |
Why?
| Autonomic Nervous System Diseases | 1 | 2000 | 11 | 0.050 |
Why?
| Prospective Studies | 5 | 2009 | 2379 | 0.050 |
Why?
| Nurse's Role | 1 | 2000 | 68 | 0.050 |
Why?
| Safety | 1 | 2000 | 77 | 0.040 |
Why?
| Drug Interactions | 1 | 2000 | 208 | 0.040 |
Why?
| Renal Insufficiency | 1 | 2001 | 109 | 0.040 |
Why?
| Patient Safety | 1 | 2020 | 102 | 0.040 |
Why?
| Arrhythmias, Cardiac | 1 | 2000 | 93 | 0.040 |
Why?
| Reference Values | 2 | 2013 | 310 | 0.040 |
Why?
| Case-Control Studies | 3 | 2013 | 1126 | 0.040 |
Why?
| Feeding Behavior | 2 | 2014 | 177 | 0.040 |
Why?
| Clinical Trials as Topic | 1 | 2000 | 466 | 0.040 |
Why?
| Postoperative Complications | 2 | 2003 | 996 | 0.040 |
Why?
| Thermolysin | 2 | 2008 | 3 | 0.040 |
Why?
| Collagenases | 2 | 2008 | 25 | 0.040 |
Why?
| Cost of Illness | 1 | 2017 | 117 | 0.030 |
Why?
| Time Factors | 4 | 2005 | 2922 | 0.030 |
Why?
| Linear Models | 2 | 2007 | 278 | 0.030 |
Why?
| School Admission Criteria | 1 | 2016 | 37 | 0.030 |
Why?
| Minisatellite Repeats | 1 | 2015 | 5 | 0.030 |
Why?
| Educational Status | 1 | 2016 | 223 | 0.030 |
Why?
| Program Development | 1 | 2016 | 167 | 0.030 |
Why?
| Logistic Models | 2 | 2009 | 889 | 0.030 |
Why?
| Cell Survival | 2 | 2008 | 602 | 0.030 |
Why?
| Optogenetics | 1 | 2015 | 5 | 0.030 |
Why?
| Treatment Outcome | 2 | 2007 | 5155 | 0.030 |
Why?
| Sensitivity and Specificity | 2 | 2013 | 863 | 0.030 |
Why?
| Genetic Association Studies | 1 | 2015 | 116 | 0.030 |
Why?
| Social Support | 1 | 2016 | 264 | 0.030 |
Why?
| Neuroimaging | 1 | 2015 | 85 | 0.030 |
Why?
| Reward | 1 | 2015 | 112 | 0.030 |
Why?
| Physical Education and Training | 1 | 2013 | 24 | 0.030 |
Why?
| Curriculum | 1 | 2016 | 400 | 0.030 |
Why?
| School Health Services | 1 | 2013 | 49 | 0.030 |
Why?
| Double-Blind Method | 2 | 2005 | 688 | 0.030 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2015 | 485 | 0.030 |
Why?
| Body Weight | 1 | 2015 | 512 | 0.030 |
Why?
| Genetic Predisposition to Disease | 1 | 2015 | 509 | 0.030 |
Why?
| ROC Curve | 1 | 2013 | 232 | 0.030 |
Why?
| Program Evaluation | 1 | 2013 | 354 | 0.030 |
Why?
| Neurons | 1 | 2015 | 460 | 0.020 |
Why?
| Diet Records | 1 | 2010 | 17 | 0.020 |
Why?
| Minerals | 1 | 2010 | 30 | 0.020 |
Why?
| Vitamins | 1 | 2010 | 64 | 0.020 |
Why?
| Echocardiography | 1 | 2013 | 375 | 0.020 |
Why?
| Physical Examination | 1 | 2009 | 90 | 0.020 |
Why?
| Diabetes Complications | 2 | 2000 | 119 | 0.020 |
Why?
| Cholesterol | 1 | 2009 | 147 | 0.020 |
Why?
| C-Peptide | 1 | 2008 | 23 | 0.020 |
Why?
| Cadaver | 1 | 2008 | 97 | 0.020 |
Why?
| Nursing Evaluation Research | 1 | 2007 | 38 | 0.020 |
Why?
| Diet, Reducing | 1 | 2007 | 36 | 0.020 |
Why?
| C-Reactive Protein | 1 | 2008 | 143 | 0.020 |
Why?
| Comorbidity | 1 | 2009 | 613 | 0.020 |
Why?
| Mice | 2 | 2008 | 5759 | 0.020 |
Why?
| Mice, Inbred NOD | 1 | 2006 | 96 | 0.020 |
Why?
| Follow-Up Studies | 2 | 2003 | 2190 | 0.020 |
Why?
| Mice, SCID | 1 | 2006 | 176 | 0.020 |
Why?
| Mass Screening | 1 | 2009 | 346 | 0.020 |
Why?
| Health Services Needs and Demand | 1 | 2007 | 158 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2013 | 3154 | 0.020 |
Why?
| Behavior Therapy | 1 | 2007 | 181 | 0.020 |
Why?
| Combined Modality Therapy | 1 | 2007 | 636 | 0.020 |
Why?
| Honey | 1 | 2004 | 8 | 0.020 |
Why?
| Gels | 1 | 2004 | 21 | 0.010 |
Why?
| Lipids | 1 | 2005 | 148 | 0.010 |
Why?
| Oxygen Consumption | 1 | 2005 | 188 | 0.010 |
Why?
| Gastrointestinal Agents | 1 | 2004 | 33 | 0.010 |
Why?
| Cross-Over Studies | 1 | 2004 | 218 | 0.010 |
Why?
| Fasting | 1 | 2003 | 70 | 0.010 |
Why?
| Prednisone | 1 | 2003 | 101 | 0.010 |
Why?
| Hormones | 1 | 2003 | 57 | 0.010 |
Why?
| Hypertension | 1 | 2008 | 537 | 0.010 |
Why?
| Cross-Sectional Studies | 1 | 2007 | 1554 | 0.010 |
Why?
| Glucose | 1 | 2004 | 338 | 0.010 |
Why?
| Animals | 2 | 2008 | 13246 | 0.010 |
Why?
| Sickness Impact Profile | 1 | 2000 | 28 | 0.010 |
Why?
| Cyclosporine | 1 | 2001 | 65 | 0.010 |
Why?
| Tacrolimus | 1 | 2001 | 52 | 0.010 |
Why?
| Signal Processing, Computer-Assisted | 1 | 2000 | 70 | 0.010 |
Why?
| Living Donors | 1 | 2000 | 23 | 0.010 |
Why?
| Hospitals, University | 1 | 2000 | 77 | 0.010 |
Why?
| Research | 1 | 2000 | 109 | 0.010 |
Why?
| Graft Survival | 1 | 2000 | 150 | 0.010 |
Why?
| Circadian Rhythm | 1 | 1999 | 89 | 0.010 |
Why?
| Disease Progression | 1 | 2001 | 831 | 0.010 |
Why?
| Risk | 1 | 1998 | 324 | 0.010 |
Why?
| Survival Rate | 1 | 2000 | 901 | 0.010 |
Why?
| Predictive Value of Tests | 1 | 1998 | 905 | 0.010 |
Why?
|
|
Cowan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
|